Alembic Ltd.

Market Capital
₹1,716 Cr.
P/E
9.02
Share Price
₹ 66.95 0.15 (0.22%)

Alembic Ltd.

Quick View
₹ 66.95 0.15 (0.22%)
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Forensics
ROE
Asset Turnover is responsible for ROE increase over last 10 years
Other Income
Other Income component is making ratios of the company look optically better
Depreciation Effect
Company is depreciating a greater percentage of assets. This is contributing to a reduction in Net Profit
Pledge
Promoters have not pledged a significant portion of their holding
Debt
Company should not have issues servicing its debt
Current vs Historic Valuation
Company is trading at a discount to 3yr historic valuations
Working Capital
Company has significant working capital which is dragging its ROCE and ROE
Revenue Recognition
Chances of aggressive revenue recognition - Operating profit of company is not getting converted to cash and recievables rising faster than sales
Capex vs ROCE
ROCE of the company has increased over the last three years
Share price
Share price has increased over last 10 years due to earnings
Contingent Liabilities
Company does not have significant contingent liabilities
Promoter Holding
Promoter has not sold any shares in the last 90 days
Retail Holding
Retail has been buying the stock which is usually a sign of exuberance
ROE
Latest
8.89%
3yr Average
15.68%
5yr Average
15.93%
Net Profit Margin
Latest
283.9%
3yr Average
398.48%
5yr Average
299.53%
ROCE
Latest
3.83%
3yr Average
3.71%
5yr Average
3.77%
Debt to Equity
Latest
-
3yr Average
0.0
5yr Average
0.0
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Operating Profit Break-Up

locked
Source
|
Latest
|
locked
Historic

Asset Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    locked
    Select a Metric
    • Domestic Sales Growth - YoY (%)
      Source
    • Management Compensation as a % of Sales (%)
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Suppliers
    Company Filing
    Show Previous Years
    Discussions & Analysis
    Alembic Ltd.
    View the discussion on ValuePickr
    Pharmaceutical Sector
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Nutraceuticals- Industry Overview - Value Educator
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Pharma Compliance In-Depth - Amit Rajan
    Deep Dive into Pharma Sector - Omkara Capital
    Phama Industry - Terminologies and Value Chain - Alpha Invesco
    How The Pharma Industry Works - PPFAS
    Real Estate Sector
    Why is Real Estate So Expensive In India - Alpha Invesco
    Metrics for REIT investing - Motley Fool
    Fund Flow from Operations(FFO) - More Relevant than Net Income and EPS for REIT's - Motley Fool
    What should you look for in an REIT? - Capital Mind
    What is a REIT - Kirtan A Shah
    Understand the Real Estate Sector - Scientific Investing
    THE BASICS: WOOD PANEL INDUSTRY - Omkara Capital
    Traverse the Indian Real Estate Universe with Anuj Puri - JioTalks
    How To Understand Accounting For Residential Real Estate - Scientific Investing
    Why Analyzing A Real Estate Company Through Financial Statements Is Misleading - Mihir Patki
    Revenue recognition in case of Real estate stocks - Ekansh Mittal
    timeline
    Sign Up for Free